ArticleAlzheimer's research & therapy2017

Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.

Christian Ulrich von Linstow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.